Skip to content 
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. more
| Time Frame | ICU | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -3.23% | -1.08% | -1.38% |
| 1-Month Return | -16.38% | -0.47% | -1.81% |
| 3-Month Return | -47.83% | 2.13% | 1.38% |
| 6-Month Return | -66.99% | 17.04% | 5.68% |
| 1-Year Return | -86.81% | 6.56% | 11.74% |
| 3-Year Return | -99.7% | 16.78% | 65.15% |
| 5-Year Return | -99.9% | 34.34% | 73.68% |
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | 135.00K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Cost of Revenue | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Gross Profit | - | - | - | - | 135.00K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Gross Margin | - | - | - | - | 100.00% | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Expenses | 6.45M | 4.45M | 11.61M | 14.21M | 17.98M | [{"date":"2020-12-31","value":35.9,"profit":true},{"date":"2021-12-31","value":24.75,"profit":true},{"date":"2022-12-31","value":64.58,"profit":true},{"date":"2023-12-31","value":79.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Income | (6.45M) | (4.45M) | (11.61M) | (14.21M) | (17.84M) | [{"date":"2020-12-31","value":-645300000,"profit":false},{"date":"2021-12-31","value":-444900000,"profit":false},{"date":"2022-12-31","value":-1160900000,"profit":false},{"date":"2023-12-31","value":-1421000000,"profit":false},{"date":"2024-12-31","value":-1784200000,"profit":false}] |
| Total Non-Operating Income/Expense | (122.00K) | (360.00K) | (11.40M) | (13.10M) | (7.13M) | [{"date":"2020-12-31","value":-12200000,"profit":false},{"date":"2021-12-31","value":-36000000,"profit":false},{"date":"2022-12-31","value":-1140300000,"profit":false},{"date":"2023-12-31","value":-1310300000,"profit":false},{"date":"2024-12-31","value":-712800000,"profit":false}] |
| Pre-Tax Income | (3.27M) | (4.60M) | (23.01M) | (26.23M) | (24.83M) | [{"date":"2020-12-31","value":-326700000,"profit":false},{"date":"2021-12-31","value":-459700000,"profit":false},{"date":"2022-12-31","value":-2301200000,"profit":false},{"date":"2023-12-31","value":-2623200000,"profit":false},{"date":"2024-12-31","value":-2482700000,"profit":false}] |
| Income Taxes | 9.00K | (1.00K) | 1.00K | (14.01K) | 3.00K | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-11.11,"profit":false},{"date":"2022-12-31","value":11.11,"profit":true},{"date":"2023-12-31","value":-155.67,"profit":false},{"date":"2024-12-31","value":33.33,"profit":true}] |
| Income After Taxes | (3.28M) | (4.60M) | (23.01M) | (26.22M) | (24.83M) | [{"date":"2020-12-31","value":-327600000,"profit":false},{"date":"2021-12-31","value":-459600000,"profit":false},{"date":"2022-12-31","value":-2301300000,"profit":false},{"date":"2023-12-31","value":-2621799000,"profit":false},{"date":"2024-12-31","value":-2483000000,"profit":false}] |
| Income From Continuous Operations | (3.28M) | (4.60M) | (23.01M) | (26.23M) | (24.83M) | [{"date":"2020-12-31","value":-327600000,"profit":false},{"date":"2021-12-31","value":-459600000,"profit":false},{"date":"2022-12-31","value":-2301300000,"profit":false},{"date":"2023-12-31","value":-2623200000,"profit":false},{"date":"2024-12-31","value":-2483000000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Net Income | (3.28M) | (4.60M) | (23.01M) | (26.23M) | (24.83M) | [{"date":"2020-12-31","value":-327600000,"profit":false},{"date":"2021-12-31","value":-459600000,"profit":false},{"date":"2022-12-31","value":-2301300000,"profit":false},{"date":"2023-12-31","value":-2623200000,"profit":false},{"date":"2024-12-31","value":-2483000000,"profit":false}] |
| EPS (Diluted) | - | 2.27 | (2.07) | (1.26) | (3.22) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-91.38,"profit":false},{"date":"2023-12-31","value":-55.79,"profit":false},{"date":"2024-12-31","value":-142.13,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| ICU | |
|---|---|
| Cash Ratio | 3.38 |
| Current Ratio | 3.66 |
| Quick Ratio | 3.64 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| ICU | |
|---|---|
| ROA (LTM) | -86.54% |
| ROE (LTM) | -290.37% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| ICU | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.26 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.74 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| ICU | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 9.96 |
| P/B | 0.78 |
| Price/FCF | NM |
| EV/R | 4.52 |
| EV/Ebitda | NM |
SeaStar Medical Holding Corporation (ICU) share price today is $2.4
Yes, Indians can buy shares of SeaStar Medical Holding Corporation (ICU) on Vested. To buy
Yes, you can purchase fractional shares of SeaStar Medical Holding Corporation (ICU) via the Vested app. You can start investing in SeaStar Medical Holding Corporation (ICU) with a minimum investment of $1.
You can invest in shares of SeaStar Medical Holding Corporation (ICU) via Vested in three simple steps:
The 52-week high price of SeaStar Medical Holding Corporation (ICU) is $25.7. The 52-week low price of SeaStar Medical Holding Corporation (ICU) is $2.2.
The price-to-earnings (P/E) ratio of SeaStar Medical Holding Corporation (ICU) is
The price-to-book (P/B) ratio of SeaStar Medical Holding Corporation (ICU) is 0.78
The dividend yield of SeaStar Medical Holding Corporation (ICU) is 0.00%
The market capitalization of SeaStar Medical Holding Corporation (ICU) is $8.78M
The stock symbol (or ticker) of SeaStar Medical Holding Corporation is ICU
Consider the share price of SeaStar Medical Holding Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether SeaStar Medical Holding Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in SeaStar Medical Holding Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the SeaStar Medical Holding Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of SeaStar Medical Holding Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that SeaStar Medical Holding Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
